Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Gentle Massage Improves Disease- and Treatment-Related Symptoms in Patients with Acute Myelogenous Leukemia.

Taylor AG, Snyder AE, Anderson JG, Brown CJ, Densmore JJ, Bourguignon C.

J Clin Trials. 2014;4. pii: 1000161.

2.

Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma.

Prichard M, Harris T, Williams ME, Densmore JJ.

Expert Opin Pharmacother. 2009 Apr;10(6):983-95. doi: 10.1517/14656560902895715 . Review.

PMID:
19364248
3.

Inherited and acquired hematologic disorders in athletes.

Densmore JJ.

Clin Adv Hematol Oncol. 2008 Feb;6(2):111-2. No abstract available.

PMID:
18347561
4.

Thrice-weekly low-dose rituximab decreases CD20 loss via shaving and promotes enhanced targeting in chronic lymphocytic leukemia.

Williams ME, Densmore JJ, Pawluczkowycz AW, Beum PV, Kennedy AD, Lindorfer MA, Hamil SH, Eggleton JC, Taylor RP.

J Immunol. 2006 Nov 15;177(10):7435-43.

5.

Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.

Redfern CH, Guthrie TH, Bessudo A, Densmore JJ, Holman PR, Janakiraman N, Leonard JP, Levy RL, Just RG, Smith MR, Rosenfelt FP, Wiernik PH, Carter WD, Gold DP, Melink TJ, Gutheil JC, Bender JF.

J Clin Oncol. 2006 Jul 1;24(19):3107-12. Epub 2006 Jun 5.

PMID:
16754937
6.

Biology and therapy of mantle cell lymphoma.

Williams ME, Densmore JJ.

Curr Opin Oncol. 2005 Sep;17(5):425-31. Review.

PMID:
16093790
7.

Hematologic disorders in the athlete.

Mercer KW, Densmore JJ.

Clin Sports Med. 2005 Jul;24(3):599-621, ix. Review.

PMID:
16004921
8.

Pegfilgrastim use during chemotherapy: current and future applications.

Wolf T, Densmore JJ.

Curr Hematol Rep. 2004 Nov;3(6):419-23. Review.

PMID:
15496275
9.

Rituximab infusion promotes rapid complement depletion and acute CD20 loss in chronic lymphocytic leukemia.

Kennedy AD, Beum PV, Solga MD, DiLillo DJ, Lindorfer MA, Hess CE, Densmore JJ, Williams ME, Taylor RP.

J Immunol. 2004 Mar 1;172(5):3280-8.

10.

Mantle cell lymphoma.

Densmore JJ, Williams ME.

Curr Treat Options Oncol. 2003 Aug;4(4):281-7.

PMID:
12943608
11.

Mantle cell lymphoma.

Densmore JJ, Williams ME.

Curr Treat Options Oncol. 2000 Aug;1(3):281-5. Review.

PMID:
12057172
12.

Calmodulin regulation of Ca2+ entry in Jurkat T cells.

Haverstick DM, Densmore JJ, Gray LS.

Cell Calcium. 1998 Jun;23(6):361-7.

PMID:
9924627
13.

A voltage-operable current is involved in Ca2+ entry in human lymphocytes whereas ICRAC has no apparent role.

Densmore JJ, Haverstick DM, Szabo G, Gray LS.

Am J Physiol. 1996 Nov;271(5 Pt 1):C1494-503.

PMID:
8944632
14.

A voltage-gated calcium channel is linked to the antigen receptor in Jurkat T lymphocytes.

Densmore JJ, Szabo G, Gray LS.

FEBS Lett. 1992 Nov 9;312(2-3):161-4.

Supplemental Content

Loading ...
Support Center